Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar antibody response study in arthritis patients receiving antirheumatic biologic therapy
2007-006539-29Phase 4Completed
- Sponsor
- Skåne University Hospital
- Start
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease, sponsored by Skåne University Hospital. Primary endpoints: Serological response to two pneumococcal serotypes and Adequate vaccine response rate. Started Dec 2007; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2007-006539-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006539-29.